IPOPI and SAFE oppose calls to reduce IG for PID patients
Read the Position Paper
This author has yet to write their bio.Meanwhile lets just say that we are proud IPOPI contributed a whooping 172 entries.
Read the Position Paper
IPOPI launched the COVID-19 Learning Expedition (LEX) in July 2020, to identify, analyse and provide recommendations on issues brought about by the COVID-19 pandemic for patients with primary immunodeficiency (PID).
IPOPI had the great pleasure of welcoming delegates from 19 countries from the Asia-Pacific region to the virtual IPOPI 3rd Regional Asian PID Meeting, held on September 18-19, 2020. During this well attended online meeting the participants learned from both international and regional primary immunodeficiencies (PID) experts on the latest developments in Asia. The meeting featured many […]
GPM, Webinars, PID Forum and more, this past 2020
Belgium
Avenue Louise/Louizalaan 65, Bte 11
BE-1050 Brussels, Belgium
IPOPI aisbl is an international non-profit association registered in Belgium
Numéro d’entreprise
BE 0761.784.055
Email: info@ipopi.org
Tel: +32 2 790 73 66 (Belgium)